Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-25.37	16.20	21.71
Graham Fair Price	41.17	424985.94	301046.70
PEG	-70.41	0.08	-0.26
Price/Book	-0.63	0.71	0.71
Price/Cash Flow	-77.02	19.78	86.07
Prices/Earnings	-48.23	7.23	13.96
Price/Sales	-5.06	1.56	1.65
Price/FCF	-77.02	19.78	86.07
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.47	0.18	0.17
Operating Margin	62.35	0.08	0.05
ROA	91.44	0.01	< 0.005
ROE	0.01	0.02	91.95
ROIC	0.01	0.02	75.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.07	57.62
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.49	0.72	47.61
EPS QOQ	-0.55	0.96	74.97
FCF QOQ	-0.84	3.37	299.37
Revenue QOQ	-0.08	0.06	-28.19
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.55	62.23	-5.05
Days Sales Outstanding (DSO)	32.23	33.77	4.76
Inventory Turnover	1.37	1.45	5.32
Debt/Capitalization	0.31	0.29	-5.40
Quick Ratio	1.03	1.01	-2.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	562473.77	573118.90	1.89
Cash	184396.02	184508.33	0.06
Capex	-15880.38	-8546.20	46.18
Free Cash Flow	4647.18	20473.57	340.56
Revenue	242736.51	258860.68	6.64
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.60	1.55	-3.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.42	4.69	-26.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating